Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-21

FDA Approved: LAMOTRIGINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for lamotrigine from Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)